- Home
- ATNM vs IGTA Comparison
ATNM vs IGTA Comparison
Compare ATNM & IGTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- IGTA
- Stock Information
- Founded
- ATNM 2000
- IGTA 2021
- Country
- ATNM United States
- IGTA United States
- Employees
- ATNM N/A
- IGTA N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- IGTA Blank Checks
- Sector
- ATNM Health Care
- IGTA Finance
- Exchange
- ATNM Nasdaq
- IGTA Nasdaq
- Market Cap
- ATNM 56.5M
- IGTA 46.2M
- IPO Year
- ATNM N/A
- IGTA 2021
- Fundamental
- Price
- ATNM $1.22
- IGTA $11.52
- Analyst Decision
- ATNM Strong Buy
- IGTA
- Analyst Count
- ATNM 5
- IGTA 0
- Target Price
- ATNM $10.20
- IGTA N/A
- AVG Volume (30 Days)
- ATNM 319.6K
- IGTA 13.9K
- Earning Date
- ATNM 11-14-2024
- IGTA 01-01-0001
- Dividend Yield
- ATNM N/A
- IGTA N/A
- EPS Growth
- ATNM N/A
- IGTA 29.68
- EPS
- ATNM N/A
- IGTA 0.12
- Revenue
- ATNM $81,000.00
- IGTA N/A
- Revenue This Year
- ATNM $186.10
- IGTA N/A
- Revenue Next Year
- ATNM $19,248.94
- IGTA N/A
- P/E Ratio
- ATNM N/A
- IGTA $99.46
- Revenue Growth
- ATNM N/A
- IGTA N/A
- 52 Week Low
- ATNM $1.16
- IGTA $10.64
- 52 Week High
- ATNM $10.24
- IGTA $12.49
- Technical
- Relative Strength Index (RSI)
- ATNM 35.90
- IGTA 32.79
- Support Level
- ATNM $1.16
- IGTA $11.65
- Resistance Level
- ATNM $1.29
- IGTA $11.75
- Average True Range (ATR)
- ATNM 0.09
- IGTA 0.10
- MACD
- ATNM 0.00
- IGTA -0.06
- Stochastic Oscillator
- ATNM 21.54
- IGTA 0.00
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About IGTA Inception Growth Acquisition Limited
Inception Growth Acquisition Ltd is a blank check company.